seeking approval to market a generic version of Auvelity in the U.S. before the expiration of applicable Axsome patents. Also Read: Axsome Reveals Data From Alzheimer’s Studies, Analyst Sees ...

KELOWNA, BC - Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW), a drug delivery platform innovator with a market capitalization of $29.84 million, has announced the issuance of two new patents by ...

Trusted by 400+ institutional investors for its intellectual honesty, thought leadership, detail-oriented, ears to the ground and a buy side approach to sell side research. The 50+ member team covers ...

Visa Inc. (NYSE:V – Free Report) – Investment analysts at Zacks Research reduced their Q2 2025 earnings per share estimates for shares of Visa in a note issued to investors on Monday ...

William Blair analyst M. Andrew expects that the medical research company will post earnings of $0.65 per share for the quarter. The consensus estimate for Edwards Lifesciences’ current full ...

8 analysts have shared their evaluations of FactSet Research Systems FDS during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a snapshot ...

Qualcomm on Wednesday forecast sales and profits above analyst expectations as artificial intelligence features helped fuel ...